Last reviewed · How we verify
Placebo patches
Placebo patches produce therapeutic effects through the placebo effect, wherein inert transdermal delivery systems trigger beneficial physiological responses based on patient expectation and psychological mechanisms.
Placebo patches produce therapeutic effects through the placebo effect, wherein inert transdermal delivery systems trigger beneficial physiological responses based on patient expectation and psychological mechanisms. Used for Pain management (various types), Symptom relief in clinical research contexts.
At a glance
| Generic name | Placebo patches |
|---|---|
| Sponsor | 424 General Military Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo patches contain no active pharmaceutical ingredient but are designed to deliver a psychological therapeutic effect through patient belief and expectation. The transdermal format and clinical context activate endogenous pain-relief and symptom-improvement pathways, including endorphin release and autonomic nervous system modulation. This mechanism relies entirely on the placebo response rather than pharmacological action.
Approved indications
- Pain management (various types)
- Symptom relief in clinical research contexts
Common side effects
- Skin irritation at application site
- Nocebo effects (negative expectancy-driven symptoms)
Key clinical trials
- Menopausal Hormones and Sympathetic Activation (PHASE4)
- Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea (PHASE3)
- NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty (NA)
- Defining Neurobiological Links Between Substance Use and Mental Illness (NA)
- Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) (PHASE3)
- Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
- Estradiol Supplementation and Rotator Cuff Repair (PHASE2)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo patches CI brief — competitive landscape report
- Placebo patches updates RSS · CI watch RSS
- 424 General Military Hospital portfolio CI